all'. One is for employees and their dependants and the other is for self-employed individuals, such as farmers and fishermen, retirees and their dependants. The 2 systems respectively cover 65.3% and 34.7% of the overall population. All prices are strictly controlled by a fee schedule that is set by the National Government, and calculated on the basis of 'fee-for-service'. The fee schedule is constant, regardless of insurance system. Furthermore, the same fee schedule applies to all clinics and hospitals that are approved to provide medical services under the public medical insurance system.
Study Population
Our study cohort comprised 4,535 Japanese beneficiaries of the National Health Insurance (NHI). Details of the cohort study have been reported elsewhere. 9, 21, 22 Briefly, the 40-69-year-old participants lived in 7 rural towns and a village in Shiga Prefecture, West Japan, and had undergone a baseline survey between 1989 and 1991. In 1990, the study area had 82,155 residents, including 31,564 individuals aged 40-69 years, of whom 11,900 were NHI beneficiaries. Therefore, the participants in the present study represented approximately 38% of all NHI beneficiaries in this age group within this community. Monthly NHI claim files for over 10 years within the Shiga NHI Organizations were linked with the baseline survey data. Deleting the names of the participants from the linked data protected their privacy. We excluded 57 participants as a result of information missing from the baseline survey. Accordingly, 4,478 participants (1,921 men and 2,557 women) were included in the analysis. The Institutional Review Board of Shiga University of Medical Science for ethical issues approved the present study (No. .
Baseline Survey and Follow-up
The baseline survey was performed by standardized methods in accordance with the Manual for Health Checkups under the Medical Service Law for the Aged, issued by the Japan Public Health Association in 1987. 23 Public health nurses measured blood pressure with a standard mercury sphygmomanometer in individuals who had rested for at least 5 min. Hypertension was defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg or taking anti-hypertensive medication. Diabetes was defined as a history of diabetes or glucosuria detected by a spot urine test with a dipstick containing a color pad. Serum high-density lipoprotein (HDL)-cholesterol and triglycerides as a marker of dyslipidemia were not measured at the baseline examination. Accordingly, dyslipidemia was defined as hypercholesterolemia with a total cholesterol level ≥5.69 mmol/L (220 mg/dl).
All participants were classified into the following categories on the basis of clustering of cardiovascular risk factors (hypertension, diabetes and hypercholesterolemia): none, 1, and 2-3. Because visceral fat accumulation was not measured at the baseline survey and the prevalence of obesity (BMI >30 kg/m 2 ) was very low (1.3%), we used a BMI of 25 kg/m 2 or greater as an indicator of being overweight in the present study. 24 Smoking and alcohol consumption habits were determined from interviews administered by the public health nurses.
Information on medical expenditures for each participant was obtained from the monthly NHI claim files, starting from April in the year following their initial health checkup until March 2001. Medical expenditures are expressed in Japanese yen and US dollars (ie, 100 Japanese yen = $US 0.848, at the exchange rates published on November 7th, 2006). Data regarding medical expenditures for each individual differed depending on the period of subscription to the NHI. The medical expenditures for each participant were therefore divided by the period of subscription, and are expressed as expenditures per month of follow-up. If a beneficiary withdrew from the NHI or died, follow-up was stopped at that point. Follow-up was restarted for beneficiaries who withdrew and then re-enrolled in the NHI.
Data Analysis
We evaluated medical expenditures per person per month in each of 3 categories according to the number of cardiovascular risk factors. Because the distribution of real medical expenditures was positively skewed, the data were logarithmically transformed to normalize the distribution and the results are expressed as geometric means. For participants with expenditures of 0 yen per month, logarithmic transformations were achieved by replacing 0 yen with 1 yen. Fifteen participants had total medical expenditures of 0 yen and 16 had outpatient medical expenditures of 0 yen. To compare total and outpatient medical expenditures per person in each category we performed an analysis of covariance after adjusting for age, sex, BMI, smoking (nonsmoker or current smoker) and alcohol consumption (none, occasional or daily consumption) with the Bonferroni correction for multiple post-hoc comparisons. A similar analysis was also performed after stratifying by BMI at 25 kg/m 2 . The significance of multiplicative interaction between risk factor clustering and being overweight for medical expenditures was examined by cross-product terms in the model. Because 2,604 participants had inpatient medical expenditures of 0 yen, logarithmic transformations were not performed, and we applied the Kruskal -Wallis test to compare inpatient medical expenditures among the 3 categories.
Furthermore, we compared the medical expenditures per person between overweight and normal weight participants with individual cardiovascular risk factors.
Finally, we calculated excess medical expenditures attributable to the number of metabolic risk factors. The excess medical expenditures were estimated as follows: ∑ [(the arithmetic mean of total medical expenditures in each of the 5 groups except for normal weight and no risk factor group, ie, (1) normal weight with 1 risk factor, (2) normal weight with 2 or 3 risk factors, (3) overweight alone, (4) overweight with 1 other risk factor, and (5) overweight with 2 or 3 other risk factors -the arithmetic mean of total medical expenditures in normal weight and no risk factor group) × (the number of individuals in each of the 5 categories.)]. We also examined the ratio of excess medical expenditure to the entire total medical expenditures of the population.
The statistical package SPSS 14.0J for Windows performed these analyses. All probability values were 2-tailed and the significance level was established at p<0.05.
Results
The prevalence of being overweight was 21.0% (men, 18.1%; women, 23.3%) of the entire study population. Table 1 summarizes the baseline risk characteristics of the 4,478 participants grouped according to risk factor clustering. Among them, 12.9% (men, 10.7%; women, 14.5%) had 2 or 3 risk factors, and 39.5% (men, 40.8%; women, 38.6%) had 1 risk factor. In both groups with 1 or more risk factors, the prevalence of hypertension was highest followed by hypercholesterolemia. Smoking and alcohol consumption did not significantly differ between the 3 groups in both men and women. The mean BMI values were higher in participants with more risk factors.
Total person-years were 40,815 and the mean follow-up was 9.0 years. Sex-specific analyses of the medical expenditures among the 3 categories showed similar results for men and women. Therefore, we reported our findings for men and women combined. Table 2 shows that during follow-up, the total medical expenditures per person per month with 2-3 risk factors (25,090 yen or $US 213) and with 1 risk factor (23,002 yen or $US 195) were higher than those in the group with no risk factors (16,400 yen or $US 139). The geometric means of total medical expenditures after adjusting for other confounding factors showed significant differences in personal medical expenditures between the 3 categories. Table 3 shows the medical expenditures per person in normal weight and overweight groups stratified by a BMI of 25.0 kg/m 2 . The total medical expenditures were highest in overweight individuals with 2-3 risk factors (26,782 yen or $US 227). On the contrary, the total medical expenditures were lowest in the normal weight group with no risk factors (15,377 yen or $US 130). The relationship between Table 4 shows the medical expenditures between overweight and normal weight participants with hypertension, hypercholesterolemia and diabetes. The medical expendi-tures per person in all 3 groups were higher in the overweight group than in the normal weight group. The difference in medical expenditures between overweight and normal weight were largest in diabetics.
The calculated excess medical expenditures attributable to normal weight individuals with 1 risk factor, those who were of normal weight with 2-3 risk factors, only overweight, overweight with 1 other risk factor and overweight with 2-3 other risk factors were 11,847,648 yen, 3,027,375 yen, 2,183,324 yen, 1,619,380 yen and 2,577,530 yen, respectively. Fig 1 shows the share of each excessive medical cost of the total medical expenditures of the entire population. The excess medical expenditures of the 2 normal weight categories combined (16.5%) were higher than Table 3 .
those of 3 overweight categories combined (7.1%).
Discussion
We performed a follow-up study of a Japanese community between 1990 and 2001 and found a positive graded relationship between clustering of cardiovascular risk factors and personal medical expenditures irrespective of being overweight. The mean personal medical cost was higher in overweight, than in normal weight individuals when the number of other risk factors was consistent. Furthermore, the total medical expenditures were the highest in overweight individuals with 2-3 risk factors. Nevertheless, the excess medical expenditures in these participants in entire population were only a few percent and the excess expenditures observed in normal weight categories were rather higher than those in overweight categories.
Findings from the Framingham study have already shown that the risk of atherosclerotic disease increases with combinations of risk factors, such as hypertension, glucose intolerance and hypercholesterolemia. 25 Japanese epidemiological studies have also found similar results in community 6 and occupational 26 settings. However, few studies to our knowledge have investigated the association between cardiovascular risk clustering or metabolic syndrome and medical expenditures. 13, 14 Most other studies have focused on the effect of hypertension combined with diabetes on medical economics. 22, 27, 28 The continuous increase in medical expenditures is an important concern in most developed countries. 29 Furthermore, the effect of cardiovascular diseases on medical economics is a major concern. For example, the medical expenditures for cardiovascular disease including hypertension was 20.4% of the total national medical expenditures in the Japanese population aged 45-69 years, which was larger than any other disease groups during 2001. 30 The effective way to control medical expenditures incurred by cardiovascular diseases is to detect those at high risk and provide intensive health and lifestyle guidance or opportunities for early clinical visits for primary care. The present findings showed that overweight people with cardiovascular risk clustering should be detected as priority targets for a high-risk strategy 31 and that overweight people with cardiovascular risk factors such as hypertension, hypercholesterolemia and diabetes can also be potential targets for high-risk strategies that could significantly affect individual medical expenditures. If an individual has accumulated visceral fat or impaired glucose tolerance, which is now classified as a metabolic syndrome, then their medical expenditures should be reduced by implementing appropriate dietary measures and by increasing physical activity.
By contrast, irrespective of high individual medical expenditures, the proportion of excess medical expenditures in the normal weight categories with 1 or more other risk factors was higher than those of all overweight categories combined. The low proportion of excess medical expenditures incurred by overweight individuals is a result of relatively small number of overweight participants identified in the present study. The 1989 to 1991 baseline survey defined only 21% of participants as being overweight (25 kg/m 2 or more). Accordingly, from the viewpoint of an entire population and a population strategy, 31 regardless of being overweight, the presence of other cardiovascular risk factors such as hypertension, diabetes and hypercholesterolemia significantly effects medical expenditures. Normal weight people with other risk factors, especially in non-Western populations with a low prevalence of obesity, should be carefully considered.
The present study has several limitations. First, the public medical insurance system in Japan differs from that in other countries. Therefore, absolute values of medical expenditures for the participants in the present study might not be directly relevant to other populations. Second, we clustered risk factors from a single measurement at the baseline survey, which generated a regression dilution bias. Third, we did not have values for fasting blood glucose, triglycerides or HDL-cholesterol, which are important components of metabolic syndrome. 15 We used BMI as an indicator of being overweight. One report indicates that waist circumference predicts visceral fat accumulation (which plays a major role on atherosclerosis) better than BMI. 32 Accordingly, we might have underestimated or misclassified obesity or being overweight by the BMI method. Finally, details of medical diagnoses, medical treatment status (eg, prescriptions), clinical condition and cause of mortality were not available. Thus, further studies are required to clarify the effects of these variables.
In conclusion, cardiovascular risk clustering and being overweight can be a useful predictor of medical expenditures. On the contrary, the sum of excess medical expenditures because of risk factor clustering in normal weight individuals is larger than that in overweight individuals because of the relatively small ratio of overweight individuals in Japan. However, the obesity epidemic is not restricted to Western countries. Furthermore, mean BMI is rapidly increasing in Asian countries such as Japan. Accordingly, being overweight might increase population medical expenditures in the future.
